Skip to main content
. 2019 Jan 24;9:716. doi: 10.1038/s41598-018-36902-2

Table 1.

Demographic characteristics in the discovery and validation cohorts.

Group Number eGFR ml/min per 1.73 m2 Age (years) Gender (% female) Disease course (months)
Discovery cohort
   Normal 5 115.9 ± 18.6 34.1 ± 7.4 20
   FSGS 5 68.5 ± 28.5 30.6 ± 11.7 20 5.0 (0.6–15.0)
Validation cohort
   Normal 20 112.3 ± 15.9 37.3 ± 9.3 40
   FSGS 20 57.7 ± 40.3 32.9 ± 17.3 40 5.7 (0.7–11.0)